2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Jose Luis Zamorano*, Patrizio Lancellotti, Daniel Rodriguez Muñoz, Victor Aboyans, Riccardo Asteggiano, Maurizio Galderisi, Gilbert Habib, Daniel J. Lenihan, Gregory Y H Lip, Alexander R. Lyon, Teresa Lopez Fernandez, Dania Mohty, Massimo F. Piepoli, Juan Tamargo, Adam Torbicki, Thomas M. Suter, Stephan Achenbach, Stefan Agewall, Lina Badimon, Gonzalo Barón-EsquiviasHelmut Baumgartner, Jeroen J. Bax, Héctor Bueno, Scipione Carerj, Veronica Dean, Çetin Erol, Donna Fitzsimons, Oliver Gaemperli, Paulus Kirchhof, Philippe Kolh, Petros Nihoyannopoulos, Piotr Ponikowski, Marco Roffi, António Vaz Carneiro, Stephan Windecker, Giorgio Minotti, Daniela Cardinale, Giuseppe Curigliano, Evandro De Azambuja, Susan Dent, Cetin Ero, Michael S. Ewer, Dimitrios Farmakis, Rainer Fietkau, Philippe Kohl, Paul McGale, Juergen Ringwald, Jeanette Schulz-Menger, Justin Stebbing, Rudolf K. Steiner, Sebastian Szmit

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1049 Citations (Scopus)
Original languageEnglish
Pages (from-to)2768-2801
Number of pages34
JournalEuropean Heart Journal
Volume37
Issue number36
DOIs
Publication statusPublished - 21 Sep 2016

Keywords

  • arrhythmias
  • cancer therapy
  • cardio-oncology
  • cardiotoxicity
  • chemotherapy
  • early detection
  • European Society of Cardiology
  • ischaemia
  • myocardial dysfunction
  • surveillance

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this